Found this posted on another board, though I would share.
Androxal (enclomiphene), being researched by Repros Therapeutics, might make history in the next couple months!!
The full writeup is here, and has a lot of information about it. It's in powerpoint format, so I wrote a small abstract. The powerpoint has lots of charts/graphs though, so if you CAN read it, DO IT!
http://www.zonagen.com/html/ppt/ice2004.ppt
My Abstract:
Clomiphene (clomid) is made up of two isomers, enclomiphene and zuclomiphene. The enclomiphene is what works on bringing up our test levels, and scary enough the zuclomiphene will actually work to LOWER test levels. So by combining these to make clomid, you get a weak(er) response, which is what we are all using for pct.
By seperating out the zuclomiphene, and only taking in enclomiphene, it was found to raise test levels significantly higher and in a much shorter time than taking in clomid. How does it sound to only take two weeks to go from ~180 ng/dl to 608 ng/dl?
So what does this mean? If all bodes well for Repros Therapeutics, and enclomiphene gets FDA approval, then we are going to have a KILLER pct drug lined up for us. They're finishing up Phase 3 of the study, which is going to go to the FDA for approval. Cross your fingers!
Some more benefits: Lower total cholesterol an average of 30 points, and lowers triglycerides by an average of 50 points, doesn't raise estradiol or DHT hardly at all... Pretty good stuff huh?
EDIT: Just for comparison sake, enclomiphene is the trans-isomer of clomiphene. And tamoxifen is the trans-isomer of the drug it is derived from, which is very close to clomiphene. So as of right now, it looks like tamoxifen (nolvadex) may actually be a better alternative to clomid for restoring testosterone levels. I know that some have already made the connection like this, but with all of the new evidence supporting the trans-isomer of serms/ae's, it might be starting to make sense.
Androxal (enclomiphene), being researched by Repros Therapeutics, might make history in the next couple months!!
The full writeup is here, and has a lot of information about it. It's in powerpoint format, so I wrote a small abstract. The powerpoint has lots of charts/graphs though, so if you CAN read it, DO IT!
http://www.zonagen.com/html/ppt/ice2004.ppt
My Abstract:
Clomiphene (clomid) is made up of two isomers, enclomiphene and zuclomiphene. The enclomiphene is what works on bringing up our test levels, and scary enough the zuclomiphene will actually work to LOWER test levels. So by combining these to make clomid, you get a weak(er) response, which is what we are all using for pct.
By seperating out the zuclomiphene, and only taking in enclomiphene, it was found to raise test levels significantly higher and in a much shorter time than taking in clomid. How does it sound to only take two weeks to go from ~180 ng/dl to 608 ng/dl?
So what does this mean? If all bodes well for Repros Therapeutics, and enclomiphene gets FDA approval, then we are going to have a KILLER pct drug lined up for us. They're finishing up Phase 3 of the study, which is going to go to the FDA for approval. Cross your fingers!
Some more benefits: Lower total cholesterol an average of 30 points, and lowers triglycerides by an average of 50 points, doesn't raise estradiol or DHT hardly at all... Pretty good stuff huh?
EDIT: Just for comparison sake, enclomiphene is the trans-isomer of clomiphene. And tamoxifen is the trans-isomer of the drug it is derived from, which is very close to clomiphene. So as of right now, it looks like tamoxifen (nolvadex) may actually be a better alternative to clomid for restoring testosterone levels. I know that some have already made the connection like this, but with all of the new evidence supporting the trans-isomer of serms/ae's, it might be starting to make sense.